MEDIA_REFRESH_DATA_PRESS_RELEASE
Media
U.S. News Room
Press Releases
Thu Dec 08 00:00:00 GMT-05:00 2022
Datopotamab Deruxtecan Showed Encouraging and Durable Efficacy in Patients with Heavily Pretreated HR Positive, HER2 Low or Negative Metastatic Breast Cancer
Download
Wed Dec 07 00:00:00 GMT-05:00 2022
ENHERTU® Achieved Statistically Significant Overall Survival Reducing the Risk of Death by 36% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast03
Download
Mon Nov 21 00:00:00 GMT-05:00 2022
Data Across Daiichi Sankyo DXd ADC Portfolio at 2022 SABCS Demonstrates Bold Progress in Advancing Treatment for Patients with Breast Cancer
Download
Mon Oct 24 00:00:00 GMT-05:00 2022
Quizartinib Granted Priority Review in the U.S. for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia
Download
Mon Oct 17 00:00:00 GMT-05:00 2022
TURALIO® New Dosing Regimen Approved in the U.S. for Certain Patients with Tenosynovial Giant Cell Tumor
Download
Mon Oct 03 00:00:00 GMT-05:00 2022
California Court Orders in Favor of Plexxikon in Dispute with Novartis
Download
Sun Sep 11 00:00:00 GMT-05:00 2022
ENHERTU® Continues to Demonstrate Clinically Meaningful Tumor Response in Patients with HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Download
Sat Sep 10 00:00:00 GMT-05:00 2022
DS-7300 Continues to Show Promising Durable Response in Patients with Several Types of Advanced Cancer
Download
Tue Sep 06 00:00:00 GMT-05:00 2022
Daiichi Sankyo Continues to Make Bold Strides in Oncology Across DXd ADC Portfolio at 2022 ESMO
Download